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Objectives: Surgical treatment of intermittent claudication is aimed primarily at improving quality of life, rather than 
survival. The aim of this study was to examine the impact of claudication on quality of life and the ability of surgeons to 
judge this. 
Design and materials: 201 claudicants rated their quality of life and completed an SF36 health status questionnaire prior 
to their first consultation. Following the consultation, the surgeons rated their perceptions of the patients" quality of 
life. 
Chief outcome measures: SF36 scores were compared with population orms. Multiple linear regression analysis 
determined the factors influencing quality of life. Agreement between surgeon and patient ratings of quality of life was 
expressed asa kappa coefficient. 
Main results: Compared to population orms, claudicants had significantly reduced quality of life in all respects. The 
severity of disease, as measured by stopping distance, was a significant predictor of general health, pain, vitality and 
physical and social parameters. Mental and emotional wellbeing were also reduced, but were not related to disease severity. 
The agreement between patient and surgeon assessments of quality of life was not high (k = 0.4). Patients had a higher 
perception of their quality of life than their surgeons. 
Conclusions: Intermittent claudication impairs quality of life in all respects. The type of treatment offered to patients 
should reflect heir quality of life at presentation, but subjective assessments by surgeons may not be sufficiently accurate. 
Health status questionnaires have been used almost exclusively in research, but they may also be of use in clinical settings 
as an objective measure of quality of life. 
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Introduction 
Intermittent claudication is a common condition 
affecting more than 5% of people over 55 years of age. 1 
Premature death results more commonly from coexist- 
ing cardiac and cerebrovascular ischaemia than from 
local progression of disease. 2'3 Only 1.6% of claudi- 
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cants ever progress to amputation, 4 but 5.5% undergo 
surgery or angioplasty each year. s Hence, surgical 
treatment is aimed primarily at alleviating symptoms 
and improving quality of life. The decision to offer 
surgery is therefore dependent on the surgeon's 
impression of the impact of claudication on the 
patient's quality of life. It is likely that the subjective 
nature of this judgement accounts, in some part, for 
the fact that surgeons differ significantly in their 
operation rates, even adjusting for case-mix and 
clinical resources. 6 Studies on the impact of peripheral 
arterial disease on quality of life have been few, and 
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have focused on patients with critical limb ischae- 
mia. 7'8 Therefore, the aims of this study were to assess 
the impact of intermittent claudication on quality of 
life and to determine the accuracy with which sur- 
geons can judge this in individual patients. 
Material and Methods 
Fourteen vascular surgeons in Scotland participated in
the study. Over a 7-month period, they recruited out- 
patients newly referred to them because of inter- 
mittent claudication. Patients who had undergone 
prior medical or surgical treatment for claudication 
were excluded. Prior to the consultation, patients 
completed an SF36 questionnaire. This is a widely 
used and well validated index of health status, 
providing scores for eight health modalities; bodily 
pain, mental health, vitality, physical and social 
functioning, physical and emotional roles and general 
health. 9-11 It was originally developed in the U.S.A. 
from the much longer index used in the Medical 
Outcomes Study. 1° Reducing the longer version facili- 
tated use of the index in clinical settings while 
maintaining its psychometric validity and the breadth 
of information provided. The U.S.A. version has been 
adapted for use in the U.K. and validated in this 
country. Several surveys have defined normal values 
for the U.K. population within different age-sex 
groups. 12,13 
In addition to the SF36 questions, patients rated 
their overall quality of life using a five-level adjectival 
scale, ranging from very poor to very good. An 
identical scale was completed independently b  the 
attending surgeon to indicate his opinion of the 
patient's quality of life. Information was also provided 
on the patient's age and sex, side and site of disease 
and severity of disease. Stopping distance was used as 
a proxy measure of disease severity. A cut-off of 200 m 
was employed as this was considered by the partici- 
pating surgeons to be the level below which symp- 
toms encroached on everyday pursuits. 
Multiple regression analysis was used to deter- 
mine which factors affected quality of life. Using 
weighted analysis of variance, the SF36 scores were 
adjusted for age and sex and compared with popula- 
tion normal values to determine if claudicants had a 
significantly different quality of life. ~2'13 The agree- 
ment between surgeon and patient assessments of
overall quality of life was expressed as a weighted 
kappa coefficient) 4 
Results 
Two hundred and one patients participated in the 
study. Their ages ranged from 36 to 87 years, with a 
mean of 64 years. One hundred and twenty-three 
(61%) patients were male and the majority (61%) had 
a stopping distance of under 200 m. In 78 (39%) cases 
referral was for right leg pain, in 87 (43%) for left leg 
pain, and the remaining 18% had bilateral claudica- 
tion. Forty-nine (24%) had predominantly aortoiliac 
disease, 113 (56%) femoropopliteal nd 40 (20%) 
mixed disease. 
Compared with published normal values, claudi- 
cants had significantly worse quality of life scores for 
all aspects of health: physical and social functioning, 
physical and emotional role, vitalit~ bodily pain and 
general health (p < 0.001) and mental health (p < 0.01). 
Table 1. Multiple linear regression analysis of factors affecting 
quality of life scores 
Regression coefficient after 
adjustment forother factors 
(level of significance) 
Severity 
Site of of 
Age Sex disease disease 
SF36 Physical -0.2 -2.6 1.5 14.8"** 
scores: functioning 
Physical -0.3 2.4 2.5 26.9*** 
role 
Bodily -0.2 -3.2 2.6 12.2"** 
pain 
Social -0.1 1.0 -0.7 15.9"* 
functioning 
Mental 0.4** -3.1 0.0 2.4 
health 
Emotional -0.4 2.8 1.4 8.5 
role 
Vitality 0.2 -3.4 -1.5 7.3* 
General 0.3 1.6 -1.0 7.2* 
health 
Overall Patient 0.0 0.2 -0.0 0.4*** 
quality of 
life ratings: Surgeon 0.0 -0.1 -0.1 0.8*** 
Level of significance of independent associations: * p<0.05; 
• *p < 0.01; ***p < 0.001. 
On multiple regression (Table 1), disease severity, 
measured by stopping distance, was significantly 
associated with SF36 scores for general health and 
vitality (p < 0.05), social functioning (p < 0.01), physical 
functioning, physical role and bodily pain (p < 0.001). 
Eur J Vasc Endovasc Surg Vol 9, May 1995 
Quality of life of Claudicants 471 
Table 2. Agreement between patients and surgeons on 













1 2 3 4 5 
Very Poor Not poor Good Very 
poor Not good good 
1 1 0 0 0 
1 9 11 10 3 
0 4 21 35 10 
0 0 15 50 17 
0 0 0 5 3 
* Data missing on five patients. 
However, disease severity did not have a significant 
effect on mental health and emotional role. Age was 
significantly associated with mental health (p < 0.01), 
but not with other modalities. The patient's ex and 
the site of disease did not affect health status. 
Disease severity significantly influenced both 
patient and surgeon assessments of overall quality of 
life (p < 0.001) (Table 1). No other factors were shown 
to be significant determinants. There was only moder- 
ate agreement between surgeon and patient assess- 
ments of overall quality of life (k= 0.4) (Table 2). 
Patients tended to rate their quality of life higher than 
their attending surgeons, with median scores of 4 
(good) and 3 (not poor/not good) respectively. 
treatments such as arterial reconstruction and percuta- 
neous transluminal angioplasty are therefore aimed 
primarily at symptomatic relief. Not all claudicants 
are offered surgery and treatment rates have been 
shown to vary significantly between surgeons. 6 Man- 
agement decisions are based on an assessment of the 
impact of the disease on a patient's quality of life 
weighed against the possible benefits and risks of 
surgery. Decision-making is also influenced by access 
to resources, 6 with priority naturally being given to 
those patients judged to be most in need. Subjective 
judgements of quality of life have therefore always 
been implicit in the surgical consultation. However, 
their accuracy has not been assessed. 
Objective measurements of the impact of periph- 
eral arterial disease on health-related quality of life 
have either been limited to patients with critical 
ischaemia 7"8'17 or have studied all patients attending 
vascular clinics with no regard to the nature or 
severity of their disease. 1s'19 Our study shows that 
intermittent claudicants have a worse quality of life 
than members of the general population, that all 
aspects of their lives are affected, not just physical 
functioning and pain, and that their quality of life 
deteriorates with increasing disease severity. In addi- 
tion, we have shown that surgeons are only moder- 
ately good at judging their patients' overall quality of 
life. If clinical decisions are to be based, in part, on 
patients' quality of life a more accurate measure is 
needed. Studies of other conditions have shown the 
SF36 questionnaire to be a valid, reliable and accept- 
able method of routinely assessing quality of life in an 
out-patient setting. 9Use of this index as an objective 
measure of quality of life may provide a useful adjunct 
to the clinical assessment of claudicants. 
Discussion 
An important priority for medical care is to save the 
lives of patients with acute conditions. However, a 
greater life-expectancy in recent years has been asso- 
ciated with an increase in the numbers of people with 
chronic and debilitating conditions. This has height- 
ened our awareness of the need to apply surgical and 
medical therapies to the task of improving health- 
related quality of life. 15 Quality of life is of such 
importance that there are situations in which patients 
would willingly trade life-expectancy to improve 
it. 16 
Most claudicants die from other causes. Local 
disease progression occurs in only one-quarter, a and 
only 1.6% will progress to amputation. 4 Surgical 
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